Psych CASC / OSCE · Consultation-liaison psychiatry
Explaining lupus-related psychosis to a partner — CASC communication station
MRCPsych/FRANZCP-style station: explain NPSLE attribution in plain language, justify infection work-up and possible immunotherapy, correct antipsychotic misunderstanding, and plan shared decisions.
On this page & tools
Target exams
Station brief
Format. Communication station, approximately 7–10 minutes after reading time. You are the psychiatry registrar meeting the partner. Rheumatology is involved. [2]
Candidate instructions. Explain that lupus can affect the brain and cause psychosis, why infection must be excluded, why steroids/immunosuppression may be needed if inflammatory NPSLE is confirmed, and that psychiatric medicines are supportive bridges. Respond to fear and blame without defensiveness. Check understanding and agree next steps. Avoid inventing legal section numbers. [1][3]
Candidate scenario
Partner: "You psychiatrists made her crazy with your drugs. Lupus is a joint disease. We are leaving. No spinal needles, no chemotherapy steroids." Bloods show low complements; psychiatry has used only short-term oral olanzapine once for severe distress. [3]
Marking domains
- Empathy, structure, non-defensive stance
- Plain-language model of NPSLE / lupus psychosis as possible immune brain involvement
- Clear infection-exclusion and investigation rationale
- Honest description of steroids/immunosuppression as disease therapy when indicated
- Balanced message on antipsychotics as supportive only
- Shared plan, understanding check, safety if discharge is demanded [2][3]
Reveal assessor key
Open. Introduce role, acknowledge fear. "I can hear how terrifying this is, and you are right to ask hard questions about causes and safety." [3]
Illness model. "Lupus can involve the nervous system. There is a recognised group of problems called neuropsychiatric lupus — including psychosis — where the immune system and inflammation can change thinking and perception. Not every psychiatric symptom is lupus, so we carefully attribute the cause rather than assume." [1][2]
Why tests. "We must make sure infection or other medical problems are not the driver, especially before stronger immune treatment. Blood tests look at lupus activity and clotting antibodies; scans and sometimes a lumbar puncture help exclude infection and support the diagnosis." [2][3]
Treatment. "If this is inflammatory lupus affecting the brain, treatment is directed at the immune disease — often high-dose steroids and sometimes stronger immunosuppression under the rheumatology team — not higher and higher psychiatric doses alone. Psychiatric medicines can reduce fear and risk while that treatment works." [2][3]
About antipsychotics. "The short-term antipsychotic was to keep her safer from extreme distress. It is not the cause of classic lupus-related psychosis in this pattern, and it is not a cure by itself." Mention anti-ribosomal P only if asked and as a possible blood clue, not a magic test. [4][3]
If they demand discharge. Explore understanding, offer second opinions, involve senior/rheumatology, assess capacity and risk, use local least-restrictive legal principles if she lacks capacity and is at serious risk — do not invent statute numbers. [2]
Close. Summarise, invite questions, written information, named follow-up. [3]
References
- [1]ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes Arthritis Rheum, 1999.PMID 10211873
- [2]Bertsias GK, Ioannidis JP, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations Ann Rheum Dis, 2010.PMID 20724309
- [3]Magro-Checa C, Zirkzee EJ, Huizinga TW, Steup-Beekman GM Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives Drugs, 2016.PMID 26809245
- [4]Isshi K, Hirohata S Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus Arthritis Rheum, 1996.PMID 8814059